The coming age of data-driven medicine: translational bioinformatics' next frontier.
Author(s): Shah, Nigam H, Tenenbaum, Jessica D
DOI: 10.1136/amiajnl-2012-000969
Author(s): Shah, Nigam H, Tenenbaum, Jessica D
DOI: 10.1136/amiajnl-2012-000969
To characterise empirical instances of Unified Medical Language System (UMLS) Metathesaurus term strings in a large clinical corpus, and to illustrate what types of term characteristics are generalisable across data sources.
Author(s): Wu, Stephen T, Liu, Hongfang, Li, Dingcheng, Tao, Cui, Musen, Mark A, Chute, Christopher G, Shah, Nigam H
DOI: 10.1136/amiajnl-2011-000744
National organizations historically focused on increasing use of effective services are now attempting to identify and discourage use of low-value services. Electronic health records (EHRs) could be used to measure use of low-value services, but few studies have examined this. The aim of the study was to: (1) determine if EHR data can be used to identify women eligible for an extended Pap testing interval; (2) determine the proportion of [...]
Author(s): Mathias, Jason S, Gossett, Dana, Baker, David W
DOI: 10.1136/amiajnl-2011-000536
Clinical integrated data repositories (IDRs) are poised to become a foundational element of biomedical and translational research by providing the coordinated data sources necessary to conduct retrospective analytic research and to identify and recruit prospective research subjects. The Clinical and Translational Science Award (CTSA) consortium's Informatics IDR Group conducted a survey of 2010 consortium members to evaluate recent trends in IDR implementation and use to support research between 2008 and [...]
Author(s): MacKenzie, Sandra L, Wyatt, Matt C, Schuff, Robert, Tenenbaum, Jessica D, Anderson, Nick
DOI: 10.1136/amiajnl-2011-000508
The spread of case-control genome-wide association studies (GWASs) has stimulated the development of new variable selection methods and predictive models. We introduce a novel Bayesian model search algorithm, Binary Outcome Stochastic Search (BOSS), which addresses the model selection problem when the number of predictors far exceeds the number of binary responses.
Author(s): Russu, Alberto, Malovini, Alberto, Puca, Annibale A, Bellazzi, Riccardo
DOI: 10.1136/amiajnl-2011-000741
Competing tools are available online to assess the risk of developing certain conditions of interest, such as cardiovascular disease. While predictive models have been developed and validated on data from cohort studies, little attention has been paid to ensure the reliability of such predictions for individuals, which is critical for care decisions. The goal was to develop a patient-driven adaptive prediction technique to improve personalized risk estimation for clinical decision [...]
Author(s): Jiang, Xiaoqian, Boxwala, Aziz A, El-Kareh, Robert, Kim, Jihoon, Ohno-Machado, Lucila
DOI: 10.1136/amiajnl-2011-000751
Quality control and harmonization of data is a vital and challenging undertaking for any successful data coordination center and a responsibility shared between the multiple sites that produce, integrate, and utilize the data. Here we describe a coordinated effort between scientists and data managers in the Cancer Family Registries to implement a data governance infrastructure consisting of both organizational and technical solutions. The technical solution uses a rule-based validation system [...]
Author(s): McGarvey, Peter B, Ladwa, Sweta, Oberti, Mauricio, Dragomir, Anca Dana, Hedlund, Erin K, Tanenbaum, David Michael, Suzek, Baris E, Madhavan, Subha
DOI: 10.1136/amiajnl-2011-000546
To study ontology modularization techniques when applied to SNOMED CT in a scenario in which no previous corpus of information exists and to examine if frequency-based filtering using MEDLINE can reduce subset size without discarding relevant concepts.
Author(s): López-García, Pablo, Boeker, Martin, Illarramendi, Arantza, Schulz, Stefan
DOI: 10.1136/amiajnl-2011-000503
Adverse drug reaction (ADR) is one of the major causes of failure in drug development. Severe ADRs that go undetected until the post-marketing phase of a drug often lead to patient morbidity. Accurate prediction of potential ADRs is required in the entire life cycle of a drug, including early stages of drug design, different phases of clinical trials, and post-marketing surveillance.
Author(s): Liu, Mei, Wu, Yonghui, Chen, Yukun, Sun, Jingchun, Zhao, Zhongming, Chen, Xue-wen, Matheny, Michael Edwin, Xu, Hua
DOI: 10.1136/amiajnl-2011-000699
Author(s): Ohno-Machado, Lucila
DOI: 10.1136/amiajnl-2012-001052